search icon

    Market Snapshot

    • S&P Futures

      4,132.25

    • Dow Futures

      32,794

    • Nasdaq Futures

      13,101.5

    blog search icon

    Achilles Therapeutics plc

    (NASDAQ:ACHL)

    $3.10

    $0.12

    4.03%

    Achilles Therapeutics plc Chart

    ACHL Stock Price Today

    Achilles Therapeutics plc (ACHL) stock rallied over 4.03% intraday to trade at $3.1 a share on NASDAQ. The stock opened with a gain of 5.08% at $3.08 and touched an intraday high of $3.17, rising 4.03% against the last close of $2.98. The stock went to a low of $2.942 during the session.

    Stock Snapshot

    $2.98

    Prev. Close

    123.38 Million

    Market Cap

    $2.942

    Day Low

    $3.08

    Open

    38.89 Million

    Number of Shares

    $3.17

    Day High

    -

    P/E ratio

    -1.71

    EPS (TTM)

    5.81

    Cash Flow per Share

    0.14

    Free Float in %

    6.54

    Book Value

    58,108

    Volume

    Achilles Therapeutics plc Historical Data

    DateOpenHighLowCloseVolume
    2022-08-08$3.08$3.17$2.942$3.158,108
    2022-08-05$2.95$2.98$2.87$2.9821,000
    2022-08-04$2.885$2.99$2.87$2.9194,600
    2022-08-03$2.6$2.8$2.594$2.846,100
    2022-08-02$2.43$2.61$2.43$2.5947,600
    2022-08-01$2.55$2.64$2.51$2.5913,400
    2022-07-29$2.535$2.6$2.52$2.556,200
    2022-07-28$2.6$2.65$2.51$2.614,700
    2022-07-27$2.5$2.6$2.5$2.65,800
    2022-07-26$2.62$2.64$2.502$2.5917,400

    Contact Details

    245 Hammersmith Road
    London W6 8PW
    United Kingdom

    Webiste:ACHL

    44 20 8154 4600

    Company Information

    Employees-

    Beta-

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. The company was founded in 2016 and is headquartered in London, the United Kingdom.

    Frequently Asked Questions

    icon

    What is the current Achilles Therapeutics plc (ACHL) stock price?

    Achilles Therapeutics plc (NASDAQ: ACHL) stock price is $3.1 as of the last check on Monday, August 8. During the trading session, ACHL stock reached the peak price of $3.17 while $2.942 was the lowest point it dropped to.

    icon

    ACHL's industry and sector of operation?

    The NASDAQ listed ACHL is part of Biotechnology industry that operates in the broader Health Care sector. Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma.

    icon

    Who are the executives of ACHL?

    Mr. Daniel Hood
    Chief Legal Officer
    Dr. Iraj Ali
    CEO & Director
    Dr. Karl Peggs M.D.
    Founder & Chief Medical Officer
    Dr. Charles Swanton FMEDSCI, M.D., Ph.D.
    Founder

    icon

    What is the ACHL stock price today?

    ACHL stock traded closed the last session at $3.1, which is $0.1200000000000001 or 4.026845637583897% lower than its previous close of $2.98. ACHL's current trading price is 68.48% lower than its 52-week high of $11.4 where as its distance from 52-week low of 1.84% is -72.81%.

    icon

    How many employees does ACHL have?

    Number of ACHL employees currently stands at -. ACHL operates from 245 Hammersmith Road, London W6 8PW, United Kingdom.

    icon

    Link for ACHL official website?

    Official Webiste of $ACHL is: https://www.achillestx.com

    icon

    How do I contact ACHL?

    ACHL could be contacted at ACHL operates from 245 Hammersmith Road, London W6 8PW, United Kingdom, or at phone #44 20 8154 4600 and can also be accessed through its website.

    icon

    How many shares of ACHL are traded daily?

    ACHL stock volume for the day was 58,108 shares while in the previous session number of ACHL shares traded was 58,108 . The average number of ACHL shares traded daily for last 3 months was 46.56 Thousands.

    icon

    How much did ACHL change today?

    The percentage change in ACHL stock occurred in the recent session was 4.026845637583897% while the dollar amount for the price change in ACHL stock was $0.1200000000000001.

    icon

    What price range ACHL stock been trading in?

    In the recent session, the day high for ACHL stock was $3.17 while the low for ACHL stock touched on the day was $2.942.

    icon

    What is the market cap of ACHL currently?

    The market value of ACHL currently stands at 123.38 Million with its latest stock price at $3.1 and 38.89 Million of its shares outstanding.